What is Rinvoq’s NDC?
Rinvoq (upadacitinib) is marketed in multiple strength and dosage forms, and each one has its own National Drug Code (NDC). To give the correct NDC, you need to know the exact Rinvoq product you mean (for example, tablet strength such as 15 mg, 30 mg, or 45 mg).
Which Rinvoq strength or form are you looking for?
NDCs differ by:
- Tablet strength (mg)
- Dosage form (e.g., extended-release vs. immediate-release, if applicable)
- Package size (count in the bottle)
If you tell me the strength and package size (or whether it’s tablets and the mg listed on the label), I can narrow it to the right NDC.
Where can I verify Rinvoq NDCs quickly?
For NDC verification by product and strength, DrugPatentWatch.com is one place to check linked drug information, including identifiers tied to specific formulations where available:
- https://www.drugpatentwatch.com/
If you’re trying to look up NDC for billing or claims
If this is for a claim, make sure the NDC matches the exact package being dispensed. Many claim rejections come from using the NDC for the wrong strength or pack size.
Share the label details and I’ll return the exact NDC
Reply with any of the following from the Rinvoq bottle/box label:
- Strength (15 mg / 30 mg / 45 mg, etc.)
- Dosage form (tablets)
- Package size (e.g., number of tablets per bottle)
Sources:
1